C07D 213/51
Acetal radicals
C07D213/51 (Acetal radicals) appears on 33 US grants and 21 published applications in this corpus.
Search patents in C07D- Granted patents
- 33
- Published applications
- 21
- Assignees
- 21
- Inventors
- 69
- Latest grant
- 12 Dec 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 3 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 3 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 1 | 0 |
| 2006 | 2 | 2 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 3 |
| 2010 | 0 | 0 |
| 2011 | 1 | 0 |
| 2012 | 1 | 2 |
| 2013 | 3 | 3 |
| 2014 | 1 | 0 |
| 2015 | 3 | 0 |
| 2016 | 0 | 1 |
| 2017 | 1 | 1 |
| 2018 | 0 | 1 |
| 2019 | 1 | 1 |
| 2020 | 0 | 1 |
| 2021 | 2 | 1 |
| 2022 | 0 | 1 |
| 2023 | 2 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 2 |
By publication year. Applications have been published since 2001.
Recent patents
- 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases12 Dec 2023US 11,840,497 B2PTC Therapeutics, Inc.
- Sulfonamide carboxamide compounds3 Oct 2023US 11,773,058 B2Inflazome Limited
- Organic anolyte materials for flow batteries6 Jul 2021US 11,056,705 B2The Board of Trustees of the University of Illinois
- 4-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases6 Apr 2021US 10,968,166 B2PTC Therapeutics, Inc.
- 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases1 Jan 2019US 10,167,251 B2Bioelectron Technology Corporation
- Macrocyclic compounds and methods of making the same13 Mar 2025US 2025/0082793 A1Janssen Biotech, Inc.
- Sortilin inhibitors2 Jan 2025US 2025/0002460 A1Sortina Pharma AB
- Novel non-coding heterocyclic amino acids (nchaa) and their use as herbicides28 Jul 2022US 2022/0232831 A1Fortephest Ltd.
- 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases17 Jun 2021US 2021/0179542 A1PTC Therapeutics, Inc.
- Novel sulfonamide carboxamide compounds22 Oct 2020US 2020/0331850 A1Inflazome Limited
Most cited
By later US patents
- Ethynylheteroaromatic-acids having retinoic acid-like activity106US 4,927,947 AAllergan, Inc. · 1990
- Ethynylheteroaromatic-acids having retinoic acid-like activity53US 4,923,884 AAllergan, Inc. · 1990
- 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases41US 7,968,746 B2Edison Pharmaceuticals, Inc. · 2011
- 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases27US 8,519,001 B2Edison Pharmaceuticals, Inc. · 2013
- 3-Amino-2-OR-propoxyaryl substituted imidazoles23US 4,134,983 AMerck & Co., Inc. · 1979